Eyconis, Inc
Company

Eyconis, Inc

Biotechnology Research 1200 Bridge Pkwy 35 employees
Employees
35
Contacts
4
Emails
4
Phones
2

Eyconis, Inc Overview

Headquarters
1200 Bridge Pkwy
Website
www.eyconis.com
Industry
Biotechnology Research
Employees
35
Founded
2024
Funding
60.3M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Eyconis, Inc

Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members.

Eyconis, Inc Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

Eyconis, Inc Org Chart

Sample employees and titles
Name Title Contact
Robert Vitti Chief Medical Officer, Eyconis, Inc
Email Phone
Nate Segraves Analytical Development and Quality
Email
Karen Chu Senior Vice President, Clinical
Email Phone
Rolf Jansen Drug Development and Manufacturing
Email

Employees by Management Level

Executive 2 profiles
Individual contributor 2 profiles

Compare Similar Companies to Eyconis, Inc